COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis
Authors:
- Kyung Mok SohnKSKyung Mok Sohn
- Sung-Gwon LeeSLSung-Gwon Lee
- Hyeon Ji KimHKHyeon Ji Kim
- Shinhyea CheonSCShinhyea Cheon
- Hyeongseok JeongHJHyeongseok Jeong
- Jooyeon LeeJLJooyeon Lee
- In Soo KimIKIn Soo Kim
- Prashanta SilwalPSPrashanta Silwal
- Chungoo ParkCPChungoo Park
- Yeon-Sook KimYKYeon-Sook Kim
- Eun-Kyeong JoEJEun-Kyeong Jo
Preprint
Abstract
Observational studies of the ongoing coronavirus disease 2019 (COVID-19) outbreak suggest that a cytokine storm is involved in the pathogenesis of severe illness. However, the molecular mechanisms underlying the altered pathological inflammation in COVID-19 are largely unknown. We report here that toll-like receptor (TLR) 4-mediated inflammatory signaling molecules are upregulated in peripheral blood mononuclear cells (PBMCs) from COVID-19 patients, compared with healthy controls. Among the most highly increased inflammatory mediators in severe/critically ill patients, S100A9, an alarmin and TLR4 ligand, was found as a noteworthy biomarker, because it inversely correlated with the serum albumin levels. These data support a link between TLR4 signaling and pathological inflammation during COVID-19 and contribute to develop therapeutic approaches through targeting TLR4-mediated inflammation.Keywords
All Related Versions
- Published version: Journal of Korean Medical Science, 35 (38).
This publication has 38 references indexed in Scilit:
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Toll-like receptors: key players in antiviral immunityCurrent Opinion in Virology, 2011
- Toll-like receptors as targets for immune disordersTrends in Pharmacological Sciences, 2011
- Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor–induced STAT1 activationProceedings of the National Academy of Sciences, 2011
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Intrinsic Cellular Defenses against Virus Infection by Antiviral Type I InterferonYonsei Medical Journal, 2010
- S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytesJournal of Cellular Biochemistry, 2007
- Signaling to NF-κB by Toll-like receptorsTrends in Molecular Medicine, 2007
- Glucocorticoids and the innate immune system: Crosstalk with the Toll-like receptor signaling networkMolecular and Cellular Endocrinology, 2007
- Toll-like receptors: From the discovery of NFκB to new insights into transcriptional regulations in innate immunityBiochemical Pharmacology, 2006